系统性炎症标志物在衰老,阿尔茨海默病和其他痴呆症中
Huimin Cai1, Tan Zhao1, Yana Pang1
1Innovation Centre for Neurological Disorders and Department of Neurology, Xuanwu Hospital, Capital Medical University, National Clinical Research Centre for Geriatric Diseases, Beijing 100053, China.
系统性炎症,特别是补充C3,互白素-1β和互白素-6,与阿尔茨海默病的发展有关. 这些标志物在衰老和疾病进展过程中显示出显著的变化,这表明炎症调节是预防和治疗的关键.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 老年学是指老年学的学科.
背景情况:
- 系统性炎症和改变的炎症标志物与衰老和阿尔茨海默病 (AD) 有关.
- 在衰老和AD期间对炎症标志物轨迹的纵向研究是有限的.
- 导致AD病变的特定炎症标志物尚不清楚.
研究的目的:
- 为了研究系统性炎症标记在衰老和AD期间的纵向变化.
- 为了确定与AD发展和进展相关的特定炎症标志物.
- 探索这些标记物在不同类型痴呆症中的特异性.
主要方法:
- 包括一个纵向队列 (n=290) 随访10年和一个横截面队列 (n=351).
- 在纵向队列中每两年测量血炎症标志物,在横截面队列中每两年测量一次.
- 对照组,临床前AD,AD和其他痴呆症亚型之间的炎症标志物水平的比较.
主要成果:
- 炎症标志物在衰老和AD发展过程中发生显著变化.
- 补充C3,中白素-1β和中白素-6显示在临床前阿尔茨海默病的显著变化,并与阿尔茨海默病发展超过10年.
- 补充C3是针对AD的特异性,而在其他痴呆症中,互白素-1β和互白素-6被改变.
结论:
- 炎症在衰老和阿尔茨海默病的发病过程中起着重要作用.
- 补充C3,IL-1β和IL-6是临床前AD和AD发展中的关键炎症标志物.
- 针对炎症可能对成功的衰老,AD预防和治疗至关重要.
更多相关视频
04:22Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease
Published on: May 20, 2024
07:08A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
Published on: October 20, 2016
相关概念视频
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Aging
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Dementia
The progression of dementia is generally gradual....
